tru4-1

Pathogenetic treatments of SARS-CoV-2 infection target:

Nanotechnology-based solutions may be employed for diagnostics of SARS-CoV-2 infection and for treatment of COVID-19.

Remdesivir and Molnupiravir belong to what class of therapeutic agents?

SARS-CoV-2 penetrates its target cells via:

Why are most of the novel specific therapies limited to hospitalised patients?